Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 320 | 96 | 3 |
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 1 | 1 | 0 |
Evaluation of Metronidazole and MK-910 in Invasive Amebiasis
S. J. Powell
S. J. Powell
Amoebiasis Research Unit, Department of Medicine of the University of Natal, Durban, South Africa
Search for other papers by S. J. Powell in
Current site
Google Scholar
PubMed
Search for other papers by S. J. Powell in
Current site
Google Scholar
PubMed
R. Elsdon-Dew
R. Elsdon-Dew
Amoebiasis Research Unit, Department of Medicine of the University of Natal, Durban, South Africa
Search for other papers by R. Elsdon-Dew in
Current site
Google Scholar
PubMed
Search for other papers by R. Elsdon-Dew in
Current site
Google Scholar
PubMed
Further trials of metronidazole in acute amebic dysentery have confirmed that a regimen of 800 mg thrice daily for 5 days is highly effective. Single daily doses of 2.0 g for 2 or 3 days produced similar results. In amebic liver abscess, 800 mg thrice daily for 5 days was effective both in curing the abscess and in eradicating Entamoeba histolytica from the bowel. Lower doses were less reliable in curing intestinal infection. In a series of trials of MK-910 in amebic dysentery and amebic liver abscess, at dosages up to 10 mg per kg of body weight daily for 5 days, the drug frequently did not eradicate E. histolytica from the bowel.
Author Notes
The Amoebiasis Research Unit is sponsored by the following bodies: The South African Research Council; The Natal Provincial Administration; The University of Natal; and The United States Public Health Service (Grant A1 09654-02).
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 320 | 96 | 3 |
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 1 | 1 | 0 |